13 November 2015Americas

Federal Circuit affirms invalidity of Lotronex patent

Roxane Laboratories’s bid to knock out Prometheus Laboratories's patent covering its Lotronex (alosetron ) product has been successful after the US Court of Appeals for the Federal Circuit affirmed that it is invalid.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk